Mini pulse is named as an intervention in 2 current clinical trials in our Egypt register. 1 is recruiting patients now. The most common phase is Phase 2/3. The sponsor with the most trials is South Valley University (1). The most-studied condition is Vitiligo, Generalized.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Vitiligo, New Treatment and Serum s100B
NCT06768840 · ClinicalTrials.gov ↗ · Vitiligo, Generalized
|
Phase 2/3 | Recruiting | South Valley University | Egypt |
|
The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.
NCT07472816 · ClinicalTrials.gov ↗ · Vitiligo
|
Phase 4 | Not yet open | Cairo University | Egypt |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| South Valley University | 1 |
| Cairo University | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Egypt | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Egypt register name Mini pulse as a drug or biological intervention, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in Egypt. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
South Valley University (1) and Cairo University (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Mini pulse works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Mini pulse works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Mini pulse (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 27 Sep 2026.